Trials / Withdrawn
WithdrawnNCT02430649
Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Prostatic Neoplasms.
Detailed description
By enrolling patients with unresectable Prostatic Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Prostatic Neoplasms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Irreversible electroporation (IRE) | |
| DEVICE | NanoKnife |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-05-20
- Completion
- 2025-01-01
- First posted
- 2015-04-30
- Last updated
- 2020-05-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02430649. Inclusion in this directory is not an endorsement.